Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Growth Hormone DisorderAdult Growth Hormone Deficiency
Interventions
DRUG

somatropin

Trial Locations (30)

1

Novo Nordisk Investigational Site, Auckland

1011

Novo Nordisk Investigational Site, Lausanne

1088

Novo Nordisk Investigational Site, Budapest

1135

Novo Nordisk Investigational Site, Budapest

1200

Novo Nordisk Investigational Site, Brussels

2303

Novo Nordisk Investigational Site, Hamilton

3010

Novo Nordisk Investigational Site, Bern

3052

Novo Nordisk Investigational Site, Parkville

6008

Novo Nordisk Investigational Site, Subiaco

6720

Novo Nordisk Investigational Site, Szeged

8036

Novo Nordisk Investigational Site, Graz

13385

Novo Nordisk Investigational Site, Marseille Cédex 05

31059

Novo Nordisk Investigational Site, Toulouse

39112

Novo Nordisk Investigational Site, Magdeburg

45122

Novo Nordisk Investigational Site, Essen

47805

Novo Nordisk Investigational Site, Krefeld

60590

Novo Nordisk Investigational Site, Frankfurt

69115

Novo Nordisk Investigational Site, Heidelberg

94275

Novo Nordisk Investigational Site, Le Kremlin-Bicêtre

04317

Novo Nordisk Investigational Site, Leipzig

0027

Novo Nordisk Investigational Site, Oslo

80-952

Novo Nordisk Investigational Site, Gdansk

30-663

Novo Nordisk Investigational Site, Krakow

71-455

Novo Nordisk Investigational Site, Szczecin

04-736

Novo Nordisk Investigational Site, Warsaw

50-376

Novo Nordisk Investigational Site, Wroclaw

08035

Novo Nordisk Investigational Site, Barcelona

413 45

Novo Nordisk Investigational Site, Gothenburg

G11 6NT

Novo Nordisk Investigational Site, Glasgow

W1N 8AA

Novo Nordisk Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY